OTCPK:EMMBF - Post by User
Comment by
deminimison Nov 10, 2017 12:31pm
172 Views
Post# 26940556
RE:RE:earnings projections
RE:RE:earnings projectionsI've spent a lot of time thinking about this as there are a numbers a variables in play that make this quarter tough to predict with precision. The supply issues weren't resolved until a couple weeks into the quarter and there was a significant price increase in mid-august but existing patients were offered a 10% discount through to the end of the quarter.
I am projecting $965K cannabis sales (with an average selling price of $8.70) from and $150K from Growwise which would be a total of $1.115M. This would be a 23.5% increase from Q1 and 107% increase over Q2. Not shooting the lights out but will be a clear signal to the market that last quarter was an aberration and that this thing is undervalued vs the rest of the sector.
They actaully had enough inventory to top $1.5M but based on their reported patient count @ Aug 25 I don't think they would have sold it all by the end of Sept. I will very happily eat my words if I am wrong though.
The more important numbers for me will be the reported inventory and patient count. If we are over 4000 patients and have at least $1M in inventory I think $2.5M in revenue is in the bag for Q4 and things will be lookin good to top $4M in Q1.
I think there may also be an interesting update on their plans for the Paris Rd property....